Evidence map›Paper›PMID 31127720›Full record

ArticleJMIR mHealth and uHealth2019

A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study.

David Koot, Paul Soo Chye Goh, Robyn Su May Lim, Yubing Tian, Teng Yan Yau, Ngiap Chuan Tan, Eric Andrew Finkelstein

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR mHealth and uHealth, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03091517 (A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes), which is not on this map. Cited by 35 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 6 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03091517 nacompletednot on this map

A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes

TypeinterventionalSponsorDuke-NUS Graduate Medical SchoolRan2017 to 2018Enrolled100ConditionsType 2 Diabetes MellitusArmsGlycoLeap
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 6 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

David KootSingHealth Polyclinics, Singapore, Singapore.ORCID 0000-0002-1570-2529
Paul Soo Chye GohSingHealth Polyclinics, Singapore, Singapore.ORCID 0000-0003-4201-9511
Robyn Su May LimHealth Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.ORCID 0000-0002-7533-7113
Yubing TianHealth Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.ORCID 0000-0003-0227-8682
Teng Yan YauKKT Technology Pte Ltd, Singapore, Singapore.ORCID 0000-0003-0252-9330
Ngiap Chuan TanSingHealth Polyclinics, Singapore, Singapore.ORCID 0000-0002-5946-1149
Eric Andrew FinkelsteinHealth Services and Systems Research, Duke-NUS Medical School, Singapore, Singapore.ORCID 0000-0001-6443-9686
National University of Singapore · SGSingHealth Polyclinics · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSingapore's current prevalence of diabetes exceeds 13.6%. Although lifestyle modification can be effective for reducing the risks for complications of type 2 diabetes mellitus (T2DM), traditional lifestyle interventions are often difficult to administer in the primary care setting due to limited resources. Mobile health apps can address these limitations by offering low-cost, adaptable, and accessible platforms for disseminating lifestyle management interventions.

objectiveUsing the RE-AIM evaluation framework, this study assessed the potential effectiveness and feasibility of GlycoLeap, a mobile lifestyle management program for people with T2DM, as an add-on to standard care.

methodsThis single-arm feasibility study recruited 100 patients with T2DM and glycated hemoglobin (HbA

resultsA total of 785 patients were approached of whom 104 consented to participate, placing the reach at 13.2%. Four were excluded after eligibility screening, and 100 patients were recruited. Program engagement (implementation) started out high but decreased with time for all evaluated components. Self-reported survey data suggest that participants monitored their blood glucose on more days in the past week at follow-up compared to baseline (P<.001) and reported positive changes to their diet due to app engagement (P<.001) (implementation). Primary outcome data were available for 83 participants. Statistically significant improvements were observed for HbA

conclusionsAlthough measures of program engagement decreased with time, clinically significant improvements in HbA

trial registrationClinicalTrials.gov NCT03091517; https://clinicaltrials.gov/ct2/show/NCT03091517 (Archived by WebCite at http://www.webcitation.org/77rNqhwRn).

Indexed as

Risk Reduction BehaviorBody Weight MaintenanceCommunity Health CentersDiabetes Mellitus, Type 2Feasibility StudiesFemaleGlycated HemoglobinHumansMaleMentoringMiddle AgedMobile ApplicationsSelf ReportSingaporeSurveys and QuestionnairesGlycated Hemoglobinhemoglobin A1c protein, humanblood glucosehealth coachingmHealthmobile appsmobile healthmobile phone appRE-AIMself-managementsingle-arm feasibility studytype 2 diabetes mellitus

Identifiers

PMID31127720
PMCPMC6555118
OpenAlexW2934896681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.